Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BioDiscovery Initiates Software Donation Program to Benefit Pediatric Research

Published: Monday, January 07, 2013
Last Updated: Monday, January 07, 2013
Bookmark and Share
Company to donate up to $100,000 worth of software licenses per year to eligible scientists working in pediatric research.

BioDiscovery, Inc. has recently launched a new software donation program to assist scientists and benefit pediatric research.

The program is aimed towards those researchers with limited resources but promising projects that will advance diagnosis and treatment of pediatric diseases.

BioDiscovery provides software solutions and services for DNA copy number, gene and miRNA expression, and methylation analysis from microarray and next-generation sequencing (NGS) technologies.

“We are really excited to be able to fund this new program to assist promising young scientists make advances in pediatric research,” said Dr. Soheil Shams, President of BioDiscovery, Inc.

Dr. Shams continued, “We know there are brilliant researchers especially those just starting their careers who have great ideas and projects but may not yet have the funds to move forward with their research. We recognize the heartache children and their families face when afflicted with a disease. Many disorders don’t have any treatment options and some cannot even be diagnosed. We believe that limitations on funding should not be an impediment in finding better treatments, especially for pediatric maladies.”

BioDiscovery has allocated $100,000 worth of software licenses per year that it will be donating to eligible researchers working on pediatric diseases.

Those interested can view the requirements and fill out the application form on the BioDiscovery website. BioDiscovery’s software solutions are designed for the end-user scientist for visualization and analysis of genomic data from aCGH, SNP, methylation and gene/miRNA expression microarrays as well as from NGS technologies.

BioDiscovery’s software is platform independent and available for Mac OS X, Linux and Windows operating systems. BioDiscovery Nexus Copy Number is the leading platform independent and user friendly application for DNA copy number analysis.

Nexus Copy Number can integrate and process together, in a single project, data from commercial array platforms such as Agilent, Affymetrix, Illumina, Roche NimbleGen, Next-Gen read depth, as well as custom arrays.

With its free access to a web-based repository for querying, and storing genomic data from any location across the globe, Nexus Copy Number is a powerful solution for large groups such as special consortia and collaborative research networks.

Nexus Expression is a complete package for analysis and visualization of gene and microRNA expression array data to identify differentially regulated probes, cluster samples and probes and identify common biological themes through gene set enrichment.

ImaGene is recognized by industry experts as the most complete solution for array image analysis with the highest quality results and the easiest to use microarray analysis user interface.

With single click automation, integrated advanced quality control parameters, numerous patented segmentation and contamination removal algorithms, and hundreds of active customers worldwide, ImaGene remains the leader in microarray image analysis.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

BioDiscovery Awarded National Institutes of Health SBIR Grant
SBIR Phase I grant to improve the copy number variation data from TCGA.
Thursday, July 10, 2014
Fox Chase Cancer Center Adopts Nexus Copy Number and Nexus Expression
The center's Keystone Program in Blood Cell Development and Cancer gains a site license for two bioinformatics software programs from BioDiscovery.
Wednesday, February 11, 2009
Scientific News
New Cancer Drug Target Found in Dual-Function Protein
Findings from a study from TSRI have shown that targeting a protein called GlyRS might help to halt cancer growth.
Contagious Cancers Are Spreading in Shellfish
Direct transmission of cancer among some marine animals may be more common than once thought, suggests a new study published in Nature by researchers at Columbia University Medical Center (CUMC).
Contagious Cancers Are Spreading in Shellfish
Direct transmission of cancer among some marine animals may be more common than once thought, suggests a new study published in Nature by researchers at Columbia University Medical Center (CUMC).
Fix for 3-Billion-Year-Old Genetic Error
Researchers at The University of Texas at Austin have developed a fix that allows RNA to accurately proofread for the first time.
Revealing the Genetic Causes of Bowel Cancer
A landmark study has given the most detailed picture yet of the genetics of bowel cancer — the UK's fourth most common cancer.
Self-Assembling Protein Shell for Drug Delivery
Made-to-order nano-cages open possibilities of shipping cargo into living cells or fashioning small chemical reactors.
Fighting Resistant Blood Cancer Cells
Biologists present new findings on chronic myeloid leukemia and possible therapeutic approaches.
Tumor Cells Develop Predictable Characteristics
Scientists have discovered that cancer cells at the edge of a tumor that are close to the surrounding environment are predictably different from the cells within the interior of the tumor.
Guided Chemotherapy Missiles
Latching chemotherapy drugs onto proteins that seek out tumors could provide a new way of treating tumors in the brain or with limited blood supply that are hard to reach with traditional chemotherapy.
Solutions for Biotherapeutic Characterization
Innovation to speed the routine.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!